BioAmber

BioAmber COO Fabrice Orecchioni named President

BioAmber Inc. (NYSE: BIOA) announced today that Jean-Francois Huc has resigned as President and CEO and Fabrice Orecchioni, the company's COO, has been named President, effective...
biosys health

Biosys Appoints Axel Wiest to Board of Directors

Biosys Health UK Limited, a clinical-stage microbiome company dedicated to the development of targeted oral immune therapies that modulate the gut microbiome, initially focused...

Alternate Health Appoints Bryan Korba as Chairman and Chief Executive Officer

Alternate Health Corp. is pleased to announce recent appointments to the Company's Board of Directors and Officers of the Company. The following Directors and Officers...

Kennet Brysting appointed General Manager, Gilead Canada

Kennet Brysting has been appointed General Manager of Gilead Sciences Canada, Inc., assuming leadership of Gilead's sixth-largest market. The former General Manager of Gilead Nordics...
NObilis

Nobilis Health Corp. appoints David Young as CFO

Nobilis Health Corp. today announced the appointment of Mr. David Young as its Chief Financial Officer.  Mr. Young brings to Nobilis extensive Fortune 500...

Shields Health Solutions Appoints Eric Suchecki to Lead the Business Development Team

Shields Health Solutions, creator of specialty pharmacies for hospitals and health systems nationwide, today announced Eric Suchecki has been appointed to the role of...

CancerGene Connect Taps Seasoned Executive John Oberg as Vice President of Sales and Marketing

CancerGene Connect, a wholly owned Subsidiary of OMMDOM, Inc., a software development, commercialization, and technology sales company whose core competency is healthcare software, has...

Medherant Announces Appointment of New Chair

 Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Dr Ken...